MediGene AG (MDGEF)
0.10
0.00 (0.00%)
USD |
OTCM |
Aug 31, 16:00
MediGene Cash from Operations (TTM)
Cash from Operations (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Operations (TTM) Data
| Date | Value |
|---|---|
| June 30, 2024 | -15.32M |
| December 31, 2023 | -16.34M |
| June 30, 2023 | -14.08M |
| December 31, 2022 | 13.50M |
| Date | Value |
|---|---|
| June 30, 2022 | 14.98M |
| December 31, 2021 | -12.81M |
| June 30, 2021 | -20.04M |
| December 31, 2020 | -28.05M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (TTM) Benchmarks
| InflaRx NV | -32.60M |
| BioNTech SE | 725.62M |
| Immatics NV | -241.73M |
| Arrowhead Pharmaceuticals, Inc. | -59.06M |
| Oncolytics Biotech, Inc. | -26.52M |